Mumbai: ABH Healthcare Limited is set to launch its ₹34.98 crore initial public offering (IPO) on August 24, with the issue attracting attention in the unofficial grey market ahead of subscription.
The company, which operates under the Anil Baghi Hospital brand, has fixed a price band of ₹96-₹102 per share. The IPO will close on August 27, 2026.
GMP At ₹27-₹30
Ahead of the issue opening, ABH Healthcare shares are reportedly trading at a grey market premium (GMP) of ₹27-₹30 per share.
At the upper price band of ₹102, the GMP indicates an unofficial premium of around 26.5%-29.4%. Grey market prices are unofficial and can change sharply before listing.
The shares are tentatively scheduled to list on the NSE SME platform on September 1.
IPO Size And Lot Details
The IPO is entirely a fresh issue of 34,29,600 equity shares with a face value of ₹10 each.
The lot size has been fixed at 1,200 shares. Retail investors will need to apply for at least two lots, or 2,400 shares, requiring about ₹2.45 lakh at the upper price band.
Of the total issue, 1,72,800 shares have been reserved for the market maker. The net public issue comprises 32,56,800 shares.
How Will Funds Be Used?
ABH Healthcare plans to use ₹17 crore from the IPO proceeds to repay or prepay certain borrowings.
Another ₹5 crore will be used for working capital needs. The remaining funds will support unidentified acquisitions and general corporate purposes.
Profit Jumps Over Threefold
The healthcare company’s consolidated revenue increased from ₹41.38 crore in FY24 to ₹52.51 crore in FY26.
EBITDA more than doubled from ₹6.89 crore to ₹14.72 crore during this period. Profit after tax increased from ₹1.66 crore to ₹5.64 crore.
Its EBITDA margin improved from 16.66% in FY24 to 28.03% in FY26.
ABH Healthcare operates a 150-bed multi-speciality hospital offering services across 25 medical specialities.
